Annual Report 2007-2008 of Sun Pharmaceutical Industries Limited

It is a broadly described annual report of Sun Pharmaceutical Industries Limited in the year of 2007-2008. During the financial year, The Company’s Total Income Rs. 32,767 million. Net Profit after Tax for the year Rs. 10,140 million. Preference Share Rs. 1/-. Equity shares final Rs. 2,175. Book value per equity share (Rs. 5 paid up) Rs. 203/-. During the year under review, The Company received notices from Foreign Currency Convertible Bond (FCCB) holders for exercising the conversion option in respect of full balance 222,214 FCCBs of US$ 1000 each Out of the total of 350,000 FCCBs thus leaving no FCCBs outstanding as on 31^st March 2008. Accordingly, The Company allotted during the year ended 31^st March 2008, 13,714,271 equity shares of Rs.5/- each of these Bondholders at the conversion price of Rs. 729.30 per share.

The Board of Directors is pleased to recommend an equity dividend of @ 210% (previous year @135%) for the year ended 31^st March 2008 on the equity share capital.

More Annual Report of Sun Pharmaceutical Industries Limited: